切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2024, Vol. 10 ›› Issue (05) : 304 -309. doi: 10.3877/cma.j.issn.2095-9141.2024.05.008

综述

微创手术及非手术方式治疗慢性硬膜下血肿的研究进展
曹文钰1, 郭鹏1, 李锦平1,()   
  1. 1.100020 北京,首都医科大学附属北京朝阳医院神经外科
  • 收稿日期:2024-04-06 出版日期:2024-10-15
  • 通信作者: 李锦平
  • 基金资助:
    朝阳区科技计划项目(CYSF2054)

Reserach progress of minimally invasive surgery and non-surgical treatment for chronic subdural hematoma

Wenyu Cao1, Peng Guo1, Jinping Li1,()   

  1. 1.Department of Neurosurgery,Beijing Chao-Yang Hospital,Capital Medical University,Beijing 100020,China
  • Received:2024-04-06 Published:2024-10-15
  • Corresponding author: Jinping Li
引用本文:

曹文钰, 郭鹏, 李锦平. 微创手术及非手术方式治疗慢性硬膜下血肿的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 304-309.

Wenyu Cao, Peng Guo, Jinping Li. Reserach progress of minimally invasive surgery and non-surgical treatment for chronic subdural hematoma[J/OL]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2024, 10(05): 304-309.

慢性硬膜下血肿(CSDH)是神经外科的常见疾病,随着人口老龄化的发展,其发病率不断升高。手术是症状性CSDH 的首选治疗方式。在微创治疗大趋势下,微创手术及非手术治疗逐渐取代传统开颅血肿清除术成为神经外科医生更为青睐的治疗方案。本文就CSDH的微创手术治疗及非手术治疗的最新进展进行综述,并探讨多种新型非手术治疗方式和多模式治疗策略,以期为临床CSDH治疗方案的优化和个体化治疗提供新的理论依据和实践方向。

Chronic subdural hematoma (CSDH) is a common condition in neurosurgery, with its incidence rising steadily due to population aging.Surgery remains the first-line treatment for symptomatic CSDH. With the growing trend toward minimally invasive approaches, minimally invasive surgery and non-surgical treatments are gradually replacing traditional craniotomy for hematoma evacuation as the preferred therapeutic options for neurosurgeons. This article provides a comprehensive review of recent advances in minimally invasive surgical and non-surgical treatments for CSDH, and explores various new non-surgical treatment methods and multimodal treatment strategies, in order to provide new theoretical basis and practical direction for the optimization and personalized treatment of clinical CSDH treatment plans.

[1]
Kudo H, Kuwamura K, Izawa I, et al. Chronic subdural hematoma in elderly people:present status on Awaji Island and epidemiological prospect[J].Neurol Med Chir (Tokyo),1992,32(4):207-209.DOI:10.2176/nmc.32.207.
[2]
Balser D, Farooq S, Mehmood T, et al. Actual and projected incidence rates for chronic subdural hematomas in United States veterans administration and civilian populations[J]. J Neurosurg,2015,123(5):1209-1215.DOI:10.3171/2014.9.Jns141550.
[3]
Weigel R, Schilling L, Krauss JK. The pathophysiology of chronic subdural hematoma revisited: emphasis on aging processes as key factor[J].Geroscience,2022,44(3):1353-1371.DOI:10.1007/s11357-022-00570-y.
[4]
Thavara BD, Kidangan GS, Rajagopalawarrier B. Comparative study of single burr - hole craniostomy versus twist - drill craniostomy in patients with chronic subdural hematoma[J]. Asian J Neurosurg,2019,14(2):513-521.DOI:10.4103/ajns.AJNS_37_19.
[5]
Solou M, Ydreos I, Gavra M, et al. Controversies in the surgical treatment of chronic subdural hematoma: a systematic scoping review[J]. Diagnostics (Basel), 2022, 12(9): 2060. DOI: 10.3390/diagnostics12092060.
[6]
Chen JW, Xu JC, Malkasian D, et al. The mini-craniotomy for cSDH revisited:new perspectives[J].Front Neurol,2021,12:660885.DOI:10.3389/fneur.2021.660885.
[7]
Link TW, Boddu S, Paine SM, et al. Middle meningeal artery embolization for chronic subdural hematoma: a series of 60 cases[J].Neurosurgery,2019,85(6):801-807.DOI:10.1093/neuros/nyy521.
[8]
Lee KS. Chronic subdural hematoma in the aged, trauma or degeneration?[J]. J Korean Neurosurg Soc, 2016, 59(1): 1-5. DOI:10.3340/jkns.2016.59.1.1.
[9]
Abecassis IJ, Kim LJ. Craniotomy for treatment of chronic subdural hematoma[J]. Neurosurg Clin N Am, 2017, 28(2): 229-237.DOI:10.1016/j.nec.2016.11.005.
[10]
Fiorella D, Arthur AS. Middle meningeal artery embolization for the management of chronic subdural hematoma[J]. J Neurointerv Surg,2019,11(9):912-915.DOI:10.1136/neurintsurg-2019-014730.
[11]
Blaauw J, Meelis GA, Jacobs B, et al. Presenting symptoms and functional outcome of chronic subdural hematoma patients[J].Acta Neurol Scand,2022,145(1):38-46.DOI:10.1111/ane.13518.
[12]
Rickard F, Gale J, Williams A, et al. New horizons in subdural haematoma[J]. Age Ageing, 2023, 52(12): afad240. DOI: 10.1093/ageing/afad240.
[13]
Kwon SM, Lee MH, Seo Y, et al. A radiological assessment of chronic subdural hematomas[J]. Korean J Neurotrauma, 2022, 18(1):12-21.DOI:10.13004/kjnt.2022.18.e24.
[14]
Hasan D, Nikoubashman O, Pjontek R, et al. MRI appearance of chronic subdural hematoma[J]. Front Neurol, 2022, 13: 872664.DOI:10.3389/fneur.2022.872664.
[15]
Stubbs DJ, Vivian ME, Davies BM, et al. Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature[J]. Acta Neurochir (Wien), 2021, 163(9): 2629-2637. DOI: 10.1007/s00701-021-04879-z.
[16]
Huang YW, Yin XS, Li ZP. Burr hole craniostomy vs.minicraniotomy of chronic subdural hematoma: a systematic review and meta-analysis[J]. Eur Rev Med Pharmacol Sci, 2022,26(14):4983-4990.DOI:10.26355/eurrev_202207_29284.
[17]
Wei Z, Jiang H, Wang Y, et al. Effect of twist-drill craniostomy with hollow screws for evacuation of chronic subdural hematoma:a meta-analysis[J].Front Neurol,2021,12:811873.DOI:10.3389/fneur.2021.811873.
[18]
Wang QP, Yuan Y, Guan JW, et al. A comparative study of irrigation versus no irrigation during burr hole craniostomy to treat chronic subdural hematoma[J]. BMC Surg, 2017, 17(1): 99. DOI:10.1186/s12893-017-0295-x.
[19]
Wan Y, Fei X, Jiang D, et al. Clinical observation of treatment of chronic subdural hematoma with novel double needle minimally invasive aspiration technology[J]. J Craniofac Surg, 2017, 28(3):646-649.DOI:10.1097/scs.0000000000003462.
[20]
Liu T, Zhao Z, Huang J, et al. Multimodality management for chronic subdural hematoma in China: protocol and characteristics of an ambidirectional, nationwide, multicenter registry study[J].Chin Neurosurg J, 2024, 10(1): 4. DOI: 10.1186/s41016-024-00356-5.
[21]
Greuter L, Lutz K, Fandino J, et al. Drain type after burr-hole drainage of chronic subdural hematoma in geriatric patients: a subanalysis of the cSDH-Drain randomized controlled trial[J].Neurosurg Focus, 2020, 49(4): E6. DOI: 10.3171/2020.7.Focus 20489.
[22]
Wu L, Ou Y, Zhu B, et al. Exhaustive drainage versus fixed-time drainage for chronic subdural hematoma after one - burr hole craniostomy (ECHO): study protocol for a multicenter randomized controlled trial[J].Trials,2023,24(1):207.DOI:10.1186/s13063-023-07250-y.
[23]
Certo F, Maione M, Altieri R, et al. Pros and cons of a minimally invasive percutaneous subdural drainage system for evacuation of chronic subdural hematoma under local anesthesia[J]. Clin Neurol Neurosurg,2019,187:105559.DOI:10.1016/j.clineuro.2019.105559.
[24]
Ramnarayan R, Arulmurugan B, Wilson PM, et al. Twist drill craniostomy with closed drainage for chronic subdural haematoma in the elderly: an effective method[J]. Clin Neurol Neurosurg, 2008,110(8):774-778.DOI:10.1016/j.clineuro.2008.04.013.
[25]
Xu M, Wang WH, Zhu SQ, et al. Effects of minimally invasive approaches on chronic subdural hematoma by novel YL-1 puncture needle and burr-hole methods[J]. Acta Neurol Belg, 2020, 120(1):37-42.DOI:10.1007/s13760-018-0914-z.
[26]
Fei X, Wan Y, Wang Z, et al. Application of YL-1 needle in chronic subdural hematoma treatment for super-aged patients[J].J Craniofac Surg, 2018, 29(1): e90-e94. DOI: 10.1097/scs.0000000 000004198.
[27]
Xu M, Tan W, Wang W, et al. Minimally invasive surgery in chronic subdural hematoma: prognosis and recurrence factors of 516 cases in a single center[J]. J Clin Med, 2022, 11(5): 1321.DOI:10.3390/jcm11051321.
[28]
Kim TG, Lee CY. Clinical and radiologic outcomes of single burr hole drainage and minicraniotomy in the treatment of inhomogeneous chronic subdural hematoma: a retrospective study[J]. Korean J Neurotrauma, 2022, 18(2): 208-220. DOI: 10.13004/kjnt.2022.18.e32.
[29]
Moshayedi P, Liebeskind DS. Middle meningeal artery embolization in chronic subdural hematoma: implications of pathophysiology in trial design[J]. Front Neurol, 2020, 11: 923. DOI: 10.3389/fneur.2020.00923.
[30]
Haldrup M, Ketharanathan B, Debrabant B, et al. Embolization of the middle meningeal artery in patients with chronic subdural hematoma-a systematic review and meta-analysis[J]. Acta Neurochir(Wien),2020,162(4):777-784.DOI:10.1007/s00701-020-04266-0.
[31]
Zuo Q, Ni W, Yang P, et al. Managing non - acute subdural hematoma using liquid materials: a Chinese randomized trial of middle meningeal artery treatment (MAGIC-MT)-protocol[J]. Trials,2023,24(1):586.DOI:10.1186/s13063-023-07608-2.
[32]
Chen H, Colasurdo M, Malhotra A, et al. Advances in chronic subdural hematoma and membrane imaging[J]. Front Neurol, 2024,15:1366238.DOI:10.3389/fneur.2024.1366238.
[33]
Kan P, Maragkos GA, Srivatsan A, et al. Middle meningeal artery embolization for chronic subdural hematoma: a multi - center experience of 154 consecutive embolizations[J]. Neurosurgery,2021,88(2):268-277.DOI:10.1093/neuros/nyaa379.
[34]
顾尧,高永军,徐蔚,等.脑膜中动脉栓塞术治疗慢性硬膜下血肿研究进展[J].中国脑血管病杂志,2022,19(9):637-641.DOI:10.3969/j.issn.1672-5921.2022.09.008.Gu Y, Gao YJ, Xu W, et al. Research progress of middle meningeal artery embolization for chronic subdural hematoma[J].Chin J Cerebrovasc Dis, 2022, 19(9): 637-641. DOI: 10.3969/j.issn.1672-5921.2022.09.008.
[35]
郭再玉,马廉亭.神经外科血管内治疗颗粒性栓塞材料的研究现状及展望[J]. 国际神经病学神经外科学杂志, 2008, 35(2):171-174.DOI:10.3969/j.issn.1673-2642.2008.02.022.Guo ZY, Ma LT. Current status and prospect of granular embolic materials in neurosurgery[J]. Journal of International Neurology and Neurosurgery,2008,35(2):171-174.DOI:10.3969/j.issn.1673-2642.2008.02.022.
[36]
盛希忠,刘作勤.非黏附性液体栓塞材料的研究现状[J].国外医学(临床放射学分册), 2006, 29(6): 422-426. DOI: 10.3784/j.issn.1674-1897.2006.06.018.Sheng XZ, Liu ZQ. Current status of non-adherent liquid embolic materials[J]. International Journal of Medical Radiology, 2006, 29(6):422-426.DOI:10.3784/j.issn.1674-1897.2006.06.018.
[37]
Mühl-Benninghaus R. Middle meningeal artery embolization for treatment of chronic subdural hematoma[J]. Radiologie (Heidelb),2022,62(Suppl 1):17-21.DOI:10.1007/s00117-022-01074-8.
[38]
Catapano JS, Nguyen CL, Wakim AA, et al. Middle meningeal artery embolization for chronic subdural hematoma[J]. Front Neurol,2020,11:557233.DOI:10.3389/fneur.2020.557233.
[39]
Wu L, Guo X, Ou Y, et al. Efficacy analysis of neuroendoscopyassisted burr-hole evacuation for chronic subdural hematoma: a systematic review and meta-analysis[J]. Neurosurg Rev, 2023, 46(1):98.DOI:10.1007/s10143-023-02007-2.
[40]
Yadav YR, Ratre S, Parihar V, et al. Endoscopic management of chronic subdural hematoma[J]. J Neurol Surg A Cent Eur Neurosurg,2020,81(4):330-341.DOI:10.1055/s-0039-1698388.
[41]
Amano T, Miyamatsu Y, Otsuji R, et al. Efficacy of endoscopic treatment for chronic subdural hematoma surgery[J]. J Clin Neurosci,2021,92:78-84.DOI:10.1016/j.jocn.2021.07.058.
[42]
Deng J, Wang F, Wang H, et al. Efficacy of neuroendoscopic treatment for septated chronic subdural hematoma[J]. Front Neurol,2021,12:765109.DOI:10.3389/fneur.2021.765109.
[43]
Aspelund A, Antila S, Proulx ST, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules[J]. J Exp Med, 2015, 212(7): 991-999. DOI: 10.1084/jem.20142290.
[44]
Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels[J]. Nature,2015,523(7560):337-341.DOI:10.1038/nature14432.
[45]
Sun T,Yuan YK,Wu K,et al.Effects of postoperative atorvastatin use in elderly patients with chronic subdural hematoma[J]. Eur Rev Med Pharmacol Sci,2021,25(23):7211-7217.DOI:10.26355/eurrev_202112_27413.
[46]
Huang J,Gao C,Dong J,et al.Drug treatment of chronic subdural hematoma[J]. Expert Opin Pharmacother, 2020, 21(4): 435-444.DOI:10.1080/14656566.2020.1713095.
[47]
Yang L, Li N, Yang L, et al. Atorvastatin-induced absorption of chronic subdural hematoma is partially attributed to the polarization of macrophages[J]. J Mol Neurosci, 2022, 72(3): 565-573.DOI:10.1007/s12031-021-01910-x.
[48]
Miah IP, Holl DC, Blaauw J, et al. Dexamethasone versus surgery for chronic subdural hematoma[J]. N Engl J Med, 2023, 388(24):2230-2240.DOI:10.1056/NEJMoa2216767.
[49]
Wang D, Gao C, Xu X, et al. Treatment of chronic subdural hematoma with atorvastatin combined with low-dose dexamethasone:phase II randomized proof-of-concept clinical trial[J]. J Neurosurg,2021,134(1):235-243.DOI:10.3171/2019.11.Jns192020.
[50]
Jiang R, Zhao S, Wang R, et al. Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized clinicaltrial[J]. JAMA Neurol, 2018, 75(11): 1338-1346. DOI: 10.1001/jamaneurol.2018.2030.
[51]
Liu X, Gao C, Yuan J, et al. Subdural haematomas drain into the extracranial lymphatic system through the meningeal lymphatic vessels[J]. Acta Neuropathol Commun, 2020, 8(1): 16. DOI:10.1186/s40478-020-0888-y.
[52]
Vychopen M, Güresir E, Wach J. Anti-inflammatory drug therapy in chronic subdural hematoma: a systematic review and metaanalysis of prospective randomized, double-blind and placebocontrolled trials[J].Int J Mol Sci,2022,23(24):16198.DOI:10.3390/ijms232416198.
[53]
Hutchinson PJ, Edlmann E, Bulters D, et al. Trial of dexamethasone for chronic subdural hematoma[J]. N Engl J Med,2020,383(27):2616-2627.DOI:10.1056/NEJMoa2020473.
[54]
Yang K, Kim KH, Lee HJ, et al. Role of adjunctive tranexamic acid in facilitating resolution of chronic subdural hematoma after surgery[J]. J Korean Neurosurg Soc, 2023, 66(4): 446-455. DOI:10.3340/jkns.2022.0200.
[55]
Immenga S, Lodewijkx R, Roos Y, et al. Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH):study protocol for a randomised placebo-controlled clinical trial[J].Trials,2022,23(1):56.DOI:10.1186/s13063-021-05907-0.
[56]
de Paula M, Ribeiro BDC, Melo MM, et al. Effect of postoperative tranexamic acid on recurrence rate and complications in chronic subdural hematomas patients: preliminary results of a randomized controlled clinical trial[J]. Neurosurg Rev, 2023, 46(1): 90. DOI:10.1007/s10143-023-01991-9.
[57]
江荣才.颅内淋巴系统的发现为颅脑创伤治疗研究打开了新视角[J]. 中华神经外科杂志, 2020, 36(10): 990-992. DOI:10.3760/cma.j.cn112050-20200330-00180.Jiang RC. The discovery of the intracranial lymphatic system opens a new perspective on the treatment of craniocerebral trauma[J].Chin J Neurosurg,2020,36(10):990-992.DOI:10.3760/cma.j.cn112050-20200330-00180.
[58]
Chen Y, Liu X, Yuan J, et al. Vitamin D accelerates the subdural hematoma clearance through improving the meningeal lymphatic vessel function[J]. Mol Cell Biochem, 2024, 479(11): 3129-3140.DOI:10.1007/s11010-023-04918-6.
[1] 朱洪宇, 曹越, 赵鑫洋, 周毅. 三孔全腔镜手术治疗中重度男性乳房发育症[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(03): 152-157.
[2] 张庆庆, 曲毅睿, 王淑君, 孙凤, 侯晓敏, 耿丽, 孙天骏. 北京市某三甲医院急诊成人烧烫伤的流行病学特征[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 324-328.
[3] 周冠宇, 谭鲁平, 杨亚晶, 李晓光. 1 916例肠道门诊食源性疾病患者病原学监测和临床特征[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 200-206.
[4] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 中国活体肝移植供者微创手术技术指南(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 241-252.
[5] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 中国活体肝移植供者微创手术技术指南(2024年版)[J/OL]. 中华移植杂志(电子版), 2024, 18(02): 74-85.
[6] 曾纪晓, 梁子建. 单孔腹腔镜手术在儿童普通外科中的应用与展望[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(02): 65-69.
[7] 张宗明, 董家鸿, 何小东, 王秋生, 徐智, 刘立民, 张翀. 老年胆道外科热点问题的争议与思考[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 754-762.
[8] 林庆喜, 曾钦霖, 谢琛璠, 魏梁锋. 封闭式钻孔引流联合阿托伐他汀治疗慢性硬膜下血肿的疗效观察[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(02): 91-96.
[9] 张薇, 郭姗姗. 轻型创伤性脑损伤远期后遗症流行病学的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(02): 117-121.
[10] 李新宇, 梁建锋. 3D打印导板辅助颅内血肿穿刺引流手术[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(06): 382-384.
[11] 栗慧慧, 林香春. 早发结直肠癌的临床特征及危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 195-200.
[12] 朱芮晴, 张荣贵, 冯秀雪, 张波, 刘圣圳, 柴宁莉, 令狐恩强. 基于倾向性评分匹配法的日间消化内镜超级微创手术治疗直肠神经内分泌肿瘤的疗效评价[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(03): 166-170.
[13] 蔡朝蓓, 陈倩倩, 宁波, 李惠凯, 袁新普, 令狐恩强. 超级微创手术模式与器官切除模式下结直肠癌患者的生活质量和心理状态变化[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(02): 81-87.
[14] 沈海锋, 吕方伊, 顾海华, 常志博, 陈盈, 王苹莉, 吴祖群, 邱福铭, 姚杰, 范军强. 局部进展期肺癌新辅助治疗后胸腔镜袖式肺叶切除术——浙江大学医学院附属第二医院2014—2023年56例回顾性分析[J/OL]. 中华胸部外科电子杂志, 2024, 11(03): 158-166.
[15] 王学建, 汪志峰, 钱明, 姜雷, 宋校伟, 胡伟梁. 比较神经内镜与钻孔引流对慢性硬膜下血肿疗效的Meta分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(02): 65-69.
阅读次数
全文


摘要